The HOX gene network in hepatocellular carcinoma

International Journal of Cancer

Volumn 129, Issue 11, 2011, Pages 2577-2587

  Cillo, Clemente ^a   Schiavo, Giulia ^b   Cantile, Monica ^c   Bihl, Michel P ^b   Sorrentino, Paolo ^a   Carafa, Vincenza ^b   D'Armiento, Maria ^a   Roncalli, Massimo ^d   Sansano, Sebastiano ^e   Vecchione, Raffaela ^a   Tornillo, Luigi ^b   Mori, Lucia ^e   De Libero, Gennaro ^e   Zucman Rossi, Jessica ^f,g   Terracciano, Luigi ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f INSERM   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

eIF4E; Hhex; HOXA13; HOXA7; nuclear export

Indexed keywords

HOMEODOMAIN PROTEIN; HOXA13 HOMEOPROTEIN; INITIATION FACTOR 4E; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HOX GENE; HOXA13 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRANSCRIPTOMICS;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LIVER; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 80053337032     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25941     Document Type: Article

References (38)

1. Bruix J, Boix L, Sala M, Llovet JM,. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215-19. (Pubitemid 38402113)
2. Zaret KS,. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 2002; 3: 499-512. (Pubitemid 34746875)
3. Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE, Jr,. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 1991; 5: 416-27. (Pubitemid 21905964)
4. Bossard P, Zaret KS,. GATA transcription factors as potentiators of gut endoderm differentiation. Development 1998; 125: 4909-17. (Pubitemid 29026772)
5. Gehring WJ, Hiromi Y,. Homeotic genes and the homeobox. Annu Rev Genet 1986; 1: 47-73.
6. Scott MP,. Vertebrate homeobox gene nomenclature. Cell 1992; 71: 551-3.
7. Graham A, Papalopulu N, Krumlauf R,. The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 1989; 57: 367-78. (Pubitemid 19126271)
8. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
9. Cillo C, Cantile M, Faiella A, Boncinelli E,. Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188: 161-9. (Pubitemid 32622906)
10. Cobb J, Duboule D,. Tracing microRNA patterns in mice. Nat Genet 2004; 36: 1033-4. (Pubitemid 41184458)
11. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY,. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-23. (Pubitemid 46962090)
12. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS,. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004; 40: 667-76. (Pubitemid 39265589)
13. Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, Jeannot E, Hérault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J,. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45: 42-52. (Pubitemid 46144363)
14. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM,. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010; 30: 35-51; PMID: 20175032.
15. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Solé M, Tovar V, Alsinet C, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008; 68: 6779-88.
16. Argiropoulos B, Humphries RK,. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007; 26: 6766-76. (Pubitemid 47585101)
17. Shaut CA, Keene DR, Sorensen LK, Li DY, Stadler HS,. HOXA13 is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet 2008; 4 (5): e1000073. doi:10.1371/journal.pgen.1000073.
18. Gu ZD, Shen LY, Wang H, Chen XM, Li Y, Ning T, Chen KN,. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma. Cancer Res 2009; 69: 4969-73.
19. Huang T, Chesnokov V, Yokoyama KK, Carr BI, Itakura K,. Expression of the Hoxa-13 gene correlates to hepatitis B and C virus associated HCC. Biochem Biophys Res Commun 2001; 281: 1041-4. (Pubitemid 32917838)
20. Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL,. Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels. Mol Cell Biol 2005; 25: 1100-12. (Pubitemid 40165816)
21. Topisirovic I, Culjkovic B, Cohen N, Perez JM, Skrabanek L, Borden KL,. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth. EMBO J 2003; 22: 689-703. (Pubitemid 36193613)
22. Bernardi R, Pandolfi PP,. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 2007; 8: 1006-16. (Pubitemid 350174636)
23. Cantile M, Procino A, D'Armiento M, Cindolo L, Cillo C,. HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis. J Cell Physiol 2003; 194: 225-36. (Pubitemid 36043637)
24. Carlile GW, Tatton WG, Borden KL,. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphateehydrogenase. Biochem J 1998; 335: 691-6. (Pubitemid 28515425)
25. Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R,. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis 2007; 28: 299-309. (Pubitemid 46321845)
26. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, Regev A, Lander ES, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009; 106: 11667-72.
27. Mortlock DP, Innis JW,. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997; 15: 179-80. (Pubitemid 27061638)
28. Jankovic D, Gorello P, Liu T, Ehret S, La Starza R, Desjobert C, Baty F, Brutsche M, Jayaraman PS, Santoro A, Mecucci C, Schwaller J,. Leukemogenic mechanisms and targets of NUP98/HHEX fusion in acute myeloid leukemia. Blood 2008; 111: 5672-82.
29. Taketani T, Taki T, Ono R, Kobayashi Y, Ida K, Hayashi Y,. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9. Genes Chromosomes Cancer 2002; 34: 437-43. (Pubitemid 34787465)
30. De Benedetti A, Graff JR,. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189-99. (Pubitemid 38638830)
31. Villaescusa JC, Buratti C, Penkov D, Mathiasen L, Planagumà J, Ferretti E, Blasi F,. Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation. PLoS One 2009; 4 (4): e5213. doi:10.1371.journal.pone.0005213.
32. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL,. eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Cell Biol 2006; 175: 415-26. (Pubitemid 44708066)
33. Ploski JE, Topisirevic I, Park KW, Borden KL, Radu A,. A mechanism of nucleocytoplasmatic trafficking for the homeoedomain protein PRH. Mol Cell Biochem 2009; 332: 173-81.
34. Herzer K, Weyer S, Krammer PH, Galle PR, Hofmann TG,. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res 2005; 65: 10830-7. (Pubitemid 41713350)
35. Katano H, Ogawa-Goto K, Hasegawa H, Kurata T, Sata T,. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. Virology 2001; 286: 446-55. (Pubitemid 32721820)
36. Kentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KL,. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci USA 2004; 101: 18105-10. (Pubitemid 40054081)
37. Assouline S, Culjkovic B, Cocolakis E, Rousseau C, Beslu N, Amri A, Caplan S, Leber B, Roy DC, Miller WH, Jr, Borden KL,. Molecular targeting of the oncogene eIF4E in AML: a proof-of-principle clinical trial with ribavirin. Blood 2009; 114: 257-60.
38. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kibicka S, Luck JM, Schirmacher P, McCombie WR, Wigler M, et al. An oncogenetic-based in vivo RNAi screen identifies tumor suppressor in liver cancer. Cell 2008; 135: 852-64.